Katy Stein | Virology Scientist
Microbiologics

Katy Stein is a Virology Scientist with Microbiologics.  She has a Ph.D in Biomedical Sciences from Icahn School of Medicine and Post Doctoral experience from Scripps Research and The Rockefeller University.  Katy has extensive expertise in virology, AAV delivery, and host-microbe interactions. Katy has experience in performing high throughput screening for the identification of virus host-entry factors and broadly neutralizing antibodies and she is proficient in developing novel vaccine platforms, previously utilizing a chimeric influenza-HA with HCMV-gH immunogen.  She  worked to harness the NOD2-activating SagA enzyme encoding Enterococcus sp. as an adjuvant and expression platform for SARS-CoV2 immunization. Katy has industry experience in process development on an analytics team, assisting both upstream and downstream with in-process testing, and recent work focusing on AAV production and capsid engineering   At Microbiologics, Katy helps customers evaluate their vaccine technologies by designing assays to support their product pipelines.